USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
30 Jun 2022 | 02:45 PM GMT

Sustainable Business Models for DTx in the US

Anchored by:

Rick Bartels
President/Founder
DTXCC
Myles Furnace
Chief Commercial Officer
EOLAS MEDICAL

Participants:

Myles Furnace Chief Commercial OfficerEolas Medical
Myles Furnace
Chief Commercial OfficerEolas Medical
Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC
Ary Deleray Digital Health Business LeaderRoche
Ary Deleray
Digital Health Business LeaderRoche
Chris Cera CEOArcweb Technologies
Chris Cera
CEOArcweb Technologies
Mindaugas Galvosas Medical Officer & Business developmentHyfe
Mindaugas Galvosas
Medical Officer & Business developmentHyfe
Ricardo C. Berrios Co-Founder & CEOAdhera Health, Inc.
Ricardo C. Berrios
Co-Founder & CEOAdhera Health, Inc.
Tatsuro Kurachi Oncology Ecosystems Platform Strategy LeadEisai Inc.
Tatsuro Kurachi
Oncology Ecosystems Platform Strategy LeadEisai Inc.

About this Meeting

Cracking the US market is no mean feat for digital health companies. For digital therapeutics (DTx), there is still no solid playbook for building a sustainable business model. Some companies head straight for the consumer market, others look to partner and build a B2B2C model, many do both.  

So how can companies plot out a business model that gives them the best chance of success? Join us to break down the opportunities and issues for DTx in the US: 

  • Direct to consumer (D2C) can be an attractive initial route to market for some companies seduced by the potential of building traction, generating real-world evidence and fast revenues. However, this model needs strong financial support, so is the D2C model sustainable in the long term?  
  • While there has been significant growth in the number of DTx - Pharma partnerships in the last few years, implementing a sustainable successful business model between the two companies remains a challenge. How can companies partner up for success?  
  • Establishing coverage and reimbursement by public and private payers will be crucial for higher DTx revenue potential. What business models require product and physicians reimbursement to be successful?  
  • Most companies have many different business models, with independent pricing models and promotional strategies. What is required to be successful and clearly differentiate business models that coexist? 
  • Flexibility in approach might be required, giving companies more options to build a successful model. How can companies organize themselves for this and stay nimble without losing focus?